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Possible adverse health effects due to the
inhalation of airborne particulate matter
(PM) are a topic of ongoing scientific and
public concern (Lippmann et al. 2003).
Recently, attention has focused on the effect
of particles with sizes < 100 nm, referred to as
ultrafine particles (Brown et al. 2000) or
nanoparticles (Nel et al. 2006; Oberdörster
et al. 2005). Interest in ultrafine particles is
due to the fact that, on the basis of the toxic-
ity of the various chemical compounds con-
tained in ambient PM, the epidemiologically
identiﬁed associations between adverse health
effects and PM are not plausible (Green et al.
2002; Valberg 2004). Hence, one needs to
explore the idea that the mere physical pres-
ence of insoluble nanoparticles deposited
deep in the lung may cause adverse effects,
including the possibility that these small par-
ticles may enter into the blood circulation
and are subsequently translocated to sensitive
body organs such as the liver, the heart, or
even the brain (Oberdörster et al. 2005). 
The toxic potential of insoluble nanoparti-
cles is commonly explored in laboratory stud-
ies involving rats or mice. A frequently studied
response parameter is lung inflammation.
In vivo studies have aimed at determining the
(physical) parameter that can serve as a rele-
vant measure of the applied dose. The knowl-
edge derived from such studies may pave the
way to identifying mechanistic pathways of
lung inﬂammation. Previous work has shown
that, for the same dose in terms of mass,
response increases with decreasing particle
size. To explain these observations, investiga-
tors have considered the surface area as the
proper dose metric (Donaldson et al. 2000;
Dufﬁn et al. 2002; Oberdörster 1996, 2000;
Oberdörster et al. 2005; Stoeger et al. 2006).
One of the problems in such studies is that
nanoparticles made from different materials
exhibit large differences in inflammogenic
potential. The surface toxicity was found to be
low for carbon, titanium dioxide, and latex
but very high for quartz, cobalt, and nickel
(Duffin et al. 2002). The origin of these
differences is not known. 
Another problem with the previous stud-
ies involving particles of low surface toxicity
is that high doses were often used in order to
observe a signiﬁcant response. Hence, heavily
nonlinear effects were observed quite fre-
quently, without being acknowledged as such
(Oberdörster 1996, 2000; Stoeger et al.
2006). Linear dose–response relationships
have also been reported, but more rarely
(Dufﬁn et al. 2002). The issues of lung over-
load and maximum tolerated doses have pre-
viously been discussed with reference to
particle-induced carcinogenesis (Mauderly
1996; McConnell 1996). In the nonlinear
dose range the inflammogenic potential of
nanoparticles cannot be quantiﬁed accurately.
Furthermore, the dose–response relationship
observed in the nonlinear dose range could
depend on parameters other than the proper
dose metric so that identiﬁcation of the latter
may become difﬁcult, if not impossible. 
Most of the previous work on lung
inﬂammation has focused on exposure involv-
ing ﬁne and ultraﬁne insoluble particles in the
size range between 20 and 250 nm. Response
to particles with sizes < 20 nm has been
explored only recently (Stoeger et al. 2006).
All of the studies had in common that conver-
sion of particle masses to surface areas was
based on the method developed by Brunauer,
Emmett, and Teller (BET; Brunauer et al.
1938). In a BET analysis the speciﬁc surface
area S—the ratio A/M of the surface area A to
the mass M of particles—is derived from the
particle’s gas absorption characteristics. The
method has become popular, partly because of
the lack of alternative techniques. Until now,
basic studies providing a direct justiﬁcation for
the use of the BET surface as a dose metric in
lung inﬂammation have not been presented.
The common approach has been to explore
whether response data measured with particles
of different size exhibit a common trend when
plotted as a function of the BET surface area
of the instilled particles. 
It is important to note that in the size
range < 20 nm, proper characterization of par-
ticle parameters becomes difﬁcult. In addition
to the BET surface area, the particle mor-
phology, the porosity, and the agglomeration
state are of key interest. Standard transmis-
sion electron microscopy (TEM) or scanning
electron microscopy (SEM) may be used to
achieve preliminary insight into particle
agglomeration and changes due to particle
transfer into aqueous solutions (Bérubé et al.
1999), such as those used for instillation.
Detailed information on the structure of
bonds between agglomerated particles can be
obtained only by high-resolution trans-
mission electron microscopy (HRTEM)
(Ishiguro et al. 1997), a technique that has
not yet been employed to characterize
nanoparticles for use in exposure studies. 
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BACKGROUND: Little is known about the mechanisms involved in lung inﬂammation caused by the
inhalation or instillation of nanoparticles. Current research focuses on identifying the particle
parameter that can serve as a proper dose metric. 
OBJECTIVES: The purpose of this study was to review published dose–response data on acute lung
inﬂammation in rats and mice after instillation of titanium dioxide particles or six types of carbon
nanoparticles. I explored four types of dose metrics: the number of particles, the joint length—that
is, the product of particle number and mean size—and the surface area deﬁned in two different ways. 
FINDINGS: With the exception of the particle size–based surface area, all other parameters worked
quite well as dose metrics, with the particle number tending to work best. The apparent mystery of
three equally useful dose metrics could be explained. Linear dose–response relationships were iden-
tified at sufficiently low doses, with no evidence of a dose threshold below which nanoparticle
instillation ceased to cause inﬂammation. In appropriately reduced form, the results for three differ-
ent sets of response parameters agreed quite well, indicating internal consistency of the data. The
reduced data revealed particle-speciﬁc differences in surface toxicity of the carbon nanoparticles, by
up to a factor of four, with diesel soot being at the low end. 
CONCLUSIONS: The analysis suggests that the physical characterization of nanoparticles and the
methods to determine surface toxicity have to be improved signiﬁcantly before the appropriate dose
metric for lung inﬂammation can be identiﬁed safely. There is also a need for reﬁnements in quan-
tifying response to exposure. 
KEY WORDS: joint length, lung inflammation, particle mass, particle number, saturation effects,
specific surface area, ultrafine carbon particles. Environ Health Perspect 114:187–194 (2006).
doi:10.1289/ehp.9254 available via http://dx.doi.org/ [Online 3 October 2006]One should also note that there is no simple
strategy for quantifying lung inﬂammation in a
straightforward manner. A common approach
to determining inflammatory response is to
measure the number of polymorphonuclear
leukocytes (PMNs) found in the bronchoalveo-
lar lavage (BAL) at some time after exposure. A
problem with this is the identiﬁcation of the
most appropriate time interval between expo-
sure and lavage. Another problem is whether
and to what extent the lavageable cells consti-
tute a sufﬁciently accurate measure of response
at all applied doses. Furthermore, the PMNs
generated in response to particle exposure are
somehow in competition with macrophages
and other cells. Hence, it becomes debatable,
notably at doses where the PMNs and the other
cells are similar in number, whether the
response should be quoted in terms of the total
number of PMNs, as a ratio or a concentration
(fraction). With these inherent complications in
mind, my aim in this study was to signiﬁcantly
extend previous attempts at identifying the
appropriate dose metric in lung inﬂammation
by ﬁne and ultraﬁne particles. 
Data and Methods
Two sets of lung inﬂammation data were con-
sidered, both involving exposure by instilla-
tion. The first study concerned 20- and
250-nm titanium dioxide (TiO2) particles in
rats (Oberdörster et al. 2000). The BET-
speciﬁc surface areas were not quoted explic-
itly but could be derived from the data in the
respective figures (50 and 6.5 m2/g, respec-
tively; specifications presumably supplied by
the particle manufacturer). The particles
appear to have been the same as those used by
another group in a study on a similar topic
(Donaldson et al. 2000). The PMNs in the
bronchoalveolar lavage were measured 24 hr
after exposure. Data analysis in terms of the
instilled BET surface area suggested virtually
identical inﬂammatory response to the TiO2
particles of different size. 
In the second study (Stoeger et al. 2006),
six different types of ultraﬁne carbon particles
were instilled in mice. The BET-speciﬁc sur-
face areas ranged from about 35 to 800 m2/g,
the mean particle sizes (by TEM) from 10 ± 2
to 45 ± 15 nm, and the organic carbon levels
between 1 and 20%. Most of the parameters
were determined by the authors or at their
request. The response parameters included the
number of PMNs and—in the BAL fluid
(BALF)—the concentrations of cytokines,
notably interleukin 1β (IL-1β), as well as the
concentrations of the macrophage inﬂamma-
tory protein 2 (MIP2). The authors concluded
that the levels of inflammatory response to
carbon particles were a) dependent on particle
type and mass, b) most strongly related to the
BET surface area, and c) became evident only
if the surface area of the instilled particles
exceeded a “threshold” of about 20 cm2. 
The data discussed below were adapted
from the figures in the original papers.
Statistical analysis was performed using the
graphics package ORIGIN 5.0 (Microcal,
Northampton, MA, USA). 
Results and Discussion
The first example, presented in Figure 1A,
shows the PMN fraction (percentage) in BAL
of rats due to intratracheal instillation of TiO2
particles (Oberdörster 2000; Oberdörster et al.
2005). The results are presented as a function
of the applied particle mass. Two observations
are noteworthy: a) As already stated in the
original work, for the same dose in terms of
mass M, there is a large difference in inﬂamma-
tory response to particles of different size.
b) For 250-nm particles, a linear dose response
appears to hold for M ≤ 0.5 mg. For 20-nm
particles, however, linearity in response is less
evident and, if present, limited M ≤ 50 μg. 
The measured data can be described by
response functions R(M) of the type
R(M) = R0 + Rm {1–exp[–(M/Mc)]}, [1]
where R0 is the zero dose response, commonly
determined in control experiments, Rm is the
assumed maximum exposure–related response
and Mc is a characteristic mass. In the limit of
small masses R(M) features a linear dose–
response relationship. For M << Mc,
R(M) = R0 + (Rm/Mc)M. [2] 
The ratio Rm/Mc may be referred to as a linear
response rate. It should be noted that, to be
useful, the chosen type of response function
must be valid for all particle sizes. Otherwise a
search for the proper dose metric would rely on
an arbitrary interpretation of experimental data. 
Taking into account R0, the three data
points per particle size, and the error bars, the
fit parameters Rm and Mc were varied until
best agreement was obtained by visual inspec-
tion. The derived fit functions are shown in
Figure 1A as thick lines, the (extrapolated)
linear section as thin lines. 
The same data are presented in Figure 1B
as a function of the BET surface area A, with
A = SBETM. The adequacy of the ﬁt functions
in the region of small surface areas is evident
from Figure 1C. In Figure 1B the presumably
linear sections of the dose–response curves for
the data—represented by solid symbols—
exhibit distinctly different slopes—repre-
sented by the dashed and solid straight lines.
The differences depend on the BET input
data. Hence, one might wonder how the spe-
cific surface areas, SBET, compare with the
numbers calculated under the assumption
that the particles were spherical. For particles
of diameter D and mass density ρ, we have
the simple relation
Ssph = A/M = 6/ρD. [3]
With ρ = 3.9 g/cm3 for the anatase modiﬁca-
tion of TiO2, one ﬁnds Ssph(20 nm) = 77 and
Ssph(250 nm) = 6.2 m2/g. The latter result is in
good agreement with SBET = 6.5 m2/g. For the
20-nm particles, on the other hand, SBET =
50 m2/g amounts to only 65% of the calcu-
lated value. This large difference is hard to
understand because any deviation from a
smooth spherical form, such as large roughness
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Figure 1. Neutrophil fraction measured in the BAL of rats in response to instillation of titanium dioxide particles of two different sizes versus particle mass (A) and
the surface area of the particles (B,C). Adapted from Oberdörster et al. (2005). The ﬁt functions according to Equations 1 and 2 are denoted by thick and thin lines,
respectively. In B and C the solid circles relate to the BET-based surface area and the open circles to the surface area derived from the particle size. Note the
logarithmic x-axis in C. Data are mean ± SD.or high porosity, would make the surface area
larger not smaller than the calculated value. 
It is worth noting that for a quantitative
comparison with calculated specific surface
areas Scal, the assumption of an exact spherical
shape of the particles is not required. In fact,
the speciﬁc surface area of a cube has exactly
the same form as Equation 3, provided the
parameter D is read as the side length of the
cube. Hence, a straightforward assessment of
the surface area does not necessarily require
particles of spherical shape. It sufﬁces to have
compact particles with similar size in all three
cartesian directions. 
Formal agreement between SBET and the
calculated speciﬁc surface areas of the 20-nm
particles might be achieved by assuming that
they have the form of cylindrical rods of
diameter Dc and length Lc, in which case
Scyl = 4(1 + Dc/2Lc)/ρDc ≈ 4/ρDc. [4]
The approximate relation on the right side of
Equation 4 holds to within 10% or better for
Lc/Dc ≥ 5. However, it is rather unlikely that
TiO2 particles in chain agglomerates are so
tightly attached to each other that they would
appear as (long) rods in the BET analysis (this
idea would also be at variance with the trend
described below for carbon nanoparticles).
Therefore, we must consider the possibility
that the BET specification was in error and
that the “true” specific surface area of the
20-nm particles was better represented by the
calculated value. Results thus obtained are
shown in Figure 1B and C as open circles and
dash–dotted lines. This alternative mass-to-
area conversion causes the initial gradients for
the two types of particles to agree quite well, a
finding that may be read as saying that the
surface area is an appropriate dose metric, pro-
vided we use the “best” method for quantify-
ing this parameter. However, a consequence of
making recourse to the calculated value of the
specific surface area would be that the
response observed with particles of distinctly
different size tends to diverge in the nonlinear
dose range, more so the larger the surface area.
Hence, I reach the conclusion, already indi-
cated in the data derived from the BET-based
mass-to-surface conversion, that measure-
ments outside the linear dose range are not
suited for testing a certain particle parameter
with respect to its use as a dose metric. 
Data presented in Figure 1C, with the sur-
face area on a logarithmic scale, can serve as a
good example for discussing the possible pres-
ence of a threshold in a dose–response relation-
ship (Oberdörster et al. 2005). If experimental
data are presented in only this way, as in a pre-
vious study showing the neutrophil response
after exposure of young rats to inhaled endo-
toxin (Oberdörster 2000), one might mistak-
enly conclude that the response is logarithmic,
as indicated by the straight dotted line. The
line suggests a threshold of about 7 cm2, but
this interpretation is incorrect because one is
not realizing that in a log-linear data presenta-
tion, a linear dose response appears initially as a
very slowly rising curve. This is exempliﬁed by
the thin solid line in Figure 1C, which is the
same as the thin straight line in Figure 1B.
Clearly, data evaluation on linear–linear scales
is indispensable when one tries to rationalize
measured dose–response data. Only with this
method can the presence of a conceivable dose
threshold be identiﬁed safely. A necessary pre-
requisite for the success of such an exercise is
the availability of sufﬁciently accurate data in
the low-dose range. The calculated response
curves in Figure 1C may be used to assess the
required data quality. 
In discussing the results of Figure 1, I
have concentrated on the dose scale. No
attention has been paid to the question of
whether the employed response parameter is
properly reflecting the magnitude of inflam-
mation induced by particle instillation. At
low doses at which the number nPMN of gen-
erated PMNs is small compared with the
number nmo of (lavageable) macrophages and
other cells, it does not make a signiﬁcant dif-
ference for the dose–response relationship
whether the response is quoted as nPMN, as
the ratio rP,m = nPMN/nmo, or as in Figure 1, as
the fraction fP,m = nPMN /(nPMN +nmo) (unless
one encounters the rare case that nmo differs
markedly at low doses). If, however, the applied
dose is sizable or large, that is, rP,m > 0.2, a
distinction between the three measures of
response becomes important. This is the case
for the two highest response data in Figure 1,
which gave rise to the conclusion that PMN
production had saturated or tended toward
saturation. The picture changes signiﬁcantly if
the PMN fractions are converted ratios
according to the relation
rP,m = fP,m/(1–fP,m). [5]
The ratios thus obtained, which are analogous
to those in Figure 1B, are shown in Figure 2.
Within experimental uncertainty, all data for
the 250-nm TiO2 particles (triangles) are now
in accordance with the assumption of a linear
dose–response relationship. The data for the
20-nm particles, on the other hand, are still
compatible with Equation 1, as illustrated by
the dashed and the dash–dotted lines. This
evaluation shows that investigators must be
concerned not only about the proper dose
metric but also about the most adequate way
of quantifying the response parameter. 
Considering the second set of data
(Stoeger et al. 2006), Figure 3A and B shows
lung inﬂammation data for exposure of mice
to instillation of different types of carbon par-
ticles. The authors chose to quantify response
in the most direct way—by the number of
PMNs found in the BAL. In order to test the
assumption that the inflammatory response
scales with the surface area, I have distin-
guished the data by particle type. Merely for
the ease of discussion, data for the same mass
are identiﬁed by different symbols. Open and
solid symbols of the same type relate to the
same mass. Deviations from a linear response
are clearly evident. The results suggest that
the upper limit of linear response corresponds
to a surface area of about 100 cm2. The data
in the nonlinear dose range are denoted by
open symbols. Selected by mass, the remain-
ing data were passed through linear regression
analyses. The results are represented by the
three straight lines in Figure 3A. Clearly, the
slopes are similar but not exactly the same;
they decrease with increasing mass. This
result could indicate that the upper limit of
linearity is even lower than 100 cm2, more
like 50 cm2. However, if that were the case,
only one experiment (PrintexG particles with
a surface area of 18 cm2) would fall into the
linear dose range for a particle mass of 50 μg.
By ﬁtting Equation 1 to the high-dose data in
Figure 3A, one obtains the thick dashed
curve. The corresponding initial linear section
is shown as a thin dashed straight line which,
in support of the adequacy of the fit, agrees
quite well with the linear ﬁt through the data
for exposure at a mass of 5 μg. 
The data presented in Figure 3B, with the
surface area on a logarithmic scale, was also
used in the original publication (Stoeger et al.
2006), but the data were distinguished by par-
ticle type. The ﬁt function used in the previ-
ous study is shown as a thick solid line. The
authors stated that “regression analysis
revealed a strong logarithmic relation for the
surface area (r2 = 0.65).” This statement is
problematic. Figure 3B shows that a logarith-
mic relation would correspond to a straight
line, but in the original ﬁt this is evident only
for surface areas above about 80 cm2, that is,
in the nonlinear dose range (see extrapolated
thin straight dash–double dotted line). The
Particle parameters relevant for lung inflammation
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Figure 2. The same data as in Figure 1B but with
the response quantiﬁed in terms of the ratio of the
number of neutrophils to the number of macro-
phages and other cells. Data are mean ± SD.apparent linearity at high doses on the loga-
rithmic scale may have led the authors to con-
clude that their data support a “threshold”
surface area of about 20 cm2. But, in an
appropriate linear presentation of the low-dose
data (Figure 3A), there is no evidence for a
threshold. The shape of a linear exposure–
response relationship with a threshold has
been discussed in a recent review (Oberdörster
et al. 2005). 
In addition I note that the experimental
data sometimes reveal the presence of signiﬁ-
cant outliers. An example relating to 20-μg
PrintexG particles is circled in Figure 3B.
This data point was excluded in the detailed
data analysis described below. 
Mass-to-surface area conversion may also
be carried out according to Equation 3, using
mean particle sizes 〈D〉 determined from the
TEM data (Takenaka S, personal communi-
cation, 2006) and a graphite mass density of
2.15 g/cm3. The used 〈D〉 values agree to
within better than 5% with the mean sizes
derived from the upper and lower size limits
quoted in the original publication (Stoeger
et al. 2006). Different from the example dis-
cussed above with reference to the TiO2 data
in Figure 1B, this approach did not provide
proper scaling of the experimental data, as
shown in Figure 3C. Note the large differ-
ences in the slopes of the straight lines repre-
senting the results of linear regression analysis
(applied only to the data represented by solid
symbols). The evaluation would also suggest
the presence of small threshold doses that
increase with increasing mass. Furthermore,
with this kind of mass-to-dose conversion, the
effect of saturation in response at high doses
appears to be removed artiﬁcially. 
The data in Figure 3C are useful because
they show clearly that the success of searching
for the proper dose metric depends critically
on the chosen particle parameter. Hence, at
this stage of data evaluation, one could have
hoped that it would be rather easy to identify
a single parameter that serves best as a dose
metric. Assuming that the BET-based surface
area is the parameter of choice, it came as a
surprise that good scaling of the experimental
data could be achieved by converting the mass
M to the number N of particles as 
N = M/〈m〉, [6] 
where 〈m〉 is the mean mass per particle,
〈m〉 = (π/6)ρ〈D3〉. [7]
As shown in Figure 3D, the scaling with parti-
cle number is better than that with the BET-
based surface area in Figure 3A, at least for the
response data being studied. There is good
agreement between the results in Figure 3A
and D in that essentially the same data points
are identiﬁed as falling into the nonlinear dose
range (assignment uncertain for one data
point located near the assumed border line
between the linear and the nonlinear sections). 
To explore the the observation that good
scaling can be achieved using two different
particle parameters, I ﬁrst considered the rela-
tion between the specific BET surface areas
(Stoeger et al. 2006) and the mean particle
size shown in Figure 4 as solid circles. Two
additional data points, shown as open circles
(CB denotes carbon black) from another
study (Donaldson et al. 2000), fit well into
the solid-circle trend. The specific surface
areas according to Equations 3 and 4 are
denoted by dashed and dash–dotted lines
(labeled “spheres” and “cylinders,” respec-
tively). The BET data agree with results
obtained for compact particles (spheres) with
sizes around 20 nm, but the smaller the parti-
cle size the more strongly the BET data
exceed the predictions for spheres. This ﬁnd-
ing could indicate that the small particles are
highly porous, notably those particles pro-
duced in a spark discharge (SpD) [the nota-
tion “ultraﬁne carbon particles” (ufCP) used
by Stoeger et al. (2006) for spark discharge
particles was not adopted here because all six
types of particles investigated by the previous
authors were ultraﬁne carbon particles]. 
An alternative explanation for the large
BET surface area could be that the spark-
generated matter contains a significant frac-
tion of very small particles (ﬂakes or chunks)
that have escaped detection in TEM analysis.
Supporting evidence for this supposition has
recently been obtained in studies on spark-
generated iridium particles analyzed by sec-
ondary ion mass spectrometry (Szymczak
et al. 2006). For particle sizes > 20 nm, the
BET data in Figure 4 are lower than calcu-
lated, approaching a ratio of 0.67 for particle
sizes > 50 nm. In this size range the BET data
formally correspond to the results calculated
for cylindrical particles (Equation 4). Note
that in the case of TiO2, the trend was just
the opposite: the 250-nm particles suggest the
presence of spheres, and the 20-nm data were
in accordance with the assumption of cylin-
drical particles. 
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observed in the sham and control experiments. Note the logarithmic x-scale in (B).Regarding the two equally useful dose
metrics, I compared the parameters of interest
in reduced form. Similar to the speciﬁc surface
area, I deﬁne the speciﬁc particle number Ns as
the number-to-mass ratio of compact particles: 
Ns = N/M = 6/πρ〈D3〉. [8]
The relation between the BET surface area
and Ns is shown in Figure 5 (solid circles).
The data for the four smallest types of parti-
cles—Printex 90 (Prtx90), flame soot with
low and high organic carbon content (SootL
and SootH, respectively) and SpD—scatter
around the dashed straight line, which reﬂects
direct proportionality between the BET sur-
face area and the particle number. This pro-
portionality is the reason that both parameters
serve equally well as dose metrics. The devia-
tion from linearity for the larger two types of
particles, diesel exhaust particles (DEP) and
PrintexG (PrtxG), does not play a large role
because they feature small surface areas and
small particle numbers and produced only
rather small responses in the exposure studies. 
The BET surface areas in Figure 4
roughly scale as 1/D2. This observation sug-
gests that there is some kind of correlation
with the (mean) joint length, 〈L〉 = N〈D〉, of
particles (Wittmaack 2002). The speciﬁc joint
lengths, Ls, deﬁned as
Ls = 〈L〉/M = 6〈D〉/πρ〈D3〉, [9]
are also plotted in Figure 5 as a function of Ns
(solid triangles, right scale). In quantitative
terms, Ls ∝ Ns
2/3; that is, the deviation from
linearity is again small for the four smallest
yet most important types of particles, which,
among each other, differed in size by a factor
of < 1.5. Hence, one can expect that the joint
length will be a third possible dose metric for
the data under consideration. Evidence is pre-
sented later in this article. 
Until now I have considered only the
results for PMNs. Data for the inﬂammatory
response derived from the concentrations of
IL-1β and MIP2 in BALF are presented in
Figures 6 and 7, respectively. In Figure 6 the
surface area was used as a dose metric and in
Figure 7 the particle number was used. In
contrast to the PMNs (Figure 3), the cytokine
concentrations in Figures 6A and 7A do not
exhibit a clear saturation in response, which
means that the data cannot be described in a
satisfactory manner by Equation 1. The result
could indicate that the response rate was
changing when going from low to high doses,
which could also provide an explanation for
the observation that the high-dose cytokine
data exhibit much larger scatter than the
PMN data. When linear regression is applied
rigorously to the low-dose results for 5 and
20 μg, the slopes of the resulting straight lines
in Figures 6A are almost the same, as one
would expect in the linear dose regime. The
two low-dose data points for 50 μg, on the
other hand, do not yield a meaningful linear
relation, which provides additional evidence
of large statistical ﬂuctuations in the measured
response. Presumably these fluctuations are
also responsible for the sizable differences in
the slopes of the low-dose linear regression
lines in Figure 7A. 
In Figures 6B and 7B, the low-dose
response data for IL-1β and MIP2 are also
presented on logarithmic dose scales, which is
to illustrate that sufﬁciently detailed measure-
ments at low doses provide a better means of
identifying the zero-dose response (or offset)
than using a rather limited number of sham
or control experiments. This is particularly
evident from Figure 7B, in which as many as
eight data points fall below the mean of the
sham and control experiments. These data
indicate that experiments of the kind dis-
cussed here are meaningful only if they are
performed carefully in the low-dose region.
Only with such data at hand can one deter-
mine the two parameters of interest, that is,
the response rate Rm/Mc and the offset R0
defined in Equation 2. Separate control
experiments are meaningful only if they are
statistically highly significant. Because of
established ethical restrictions on the number
of animals available for one particular study,
low-dose experiments should be given prefer-
ence to control experiments.
Considering the results of Figures 3A, D,
and 6A, one could conclude that the particle
number and the surface area are both suited as
a dose metric. In other words, all response data
obtained at low doses may be combined,
regardless of mass, to yield one data set that
allows Rm/Mc and R0 to be determined with a
statistical significance that will be markedly
improved compared with the analysis of data
for one response parameter only. In the actual
evaluation, 12 low-dose data points were
included in the PMN set, 13 each in the IL-1β
and the MIP2 sets. The data are presented in
Figure 8 as a function of three dose metrics:
the BET surface area, the particle number and,
additionally, the joint length (the large amount
of particulate matter instilled at the upper end
of the linear dose range is evident from the
abscissa in Figure 8B, which shows that the
data extend to joint lengths of > 150 km).
Linear regression analysis of the data in
Figure 8 yielded nine sets of results for Rm/Mc
and R0 as well as the respective values for r2
and p. The statistically most signiﬁcant results
were obtained for PMNs, with r2 between a
low for the surface area (0.79) and a high for
the particle number (0.91) and p < 10–4
throughout. The MIP2 data produced statisti-
cally least satisfactory results, ranging from r2 =
0.53 (p = 5 × 10–3) for the length to r2 = 0.69
(p = 4.4 × 10–4) for the surface area. After sub-
tracting R0 from the respective data set, the off-
set-corrected responses were divided by the
Particle parameters relevant for lung inflammation
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Adapted from Stoeger et al. (2006).mean to determine 3 × 3 sets of scaled response
data Ri,φ for response type i and dose φ. The
results are shown in Figure 8A, B, and C as
open symbols. The three sets of data in each
panel were finally weighed with r2 and then
used to calculate the mean 〈R〉φ and the SD of
the mean 〈ΔR〉φ. Several conclusions can be
drawn from the results in Figure 8: 
a) The scaled responses Ri,φ, with i repre-
senting PMNs, IL-1β, and MIP2, agree quite
well. Even the most extreme “outliers” do not
deviate by more than 2〈ΔR〉φ from 〈R〉φ. None
of the Ri,φ values exhibit an unusual trend as
to the sign of the deviations from 〈R〉φ. The
deviations appear to be solely statistical in
nature. This implies that the relative magni-
tude of the response initiated by exposure to
the ultrafine carbon particles is the same for
all three types of responses that were used to
explore lung inflammation on the basis of
cellular and molecular matter found in BAL. 
b) Linear regression analysis of the 〈R〉φ
data yielded the straight lines shown in
Figure 8A–C. The corresponding r2 values
were 0.76 (joint length), 0.82 (BET surface
area) and 0.84 (particle number), all with
p ≤ 10–4. Several of the 〈R〉φ data exhibit statis-
tically signiﬁcant deviations from the straight
lines. Two examples are encircled. The positive
deviation is due to SpD (5 μg) and the negative
is due to DEP (20 μg). If these two data and
〈R〉φ for DEP (50 μg; not highlighted) are
excluded from the regression analysis, the
resulting r2 values improve significantly, but
the “order” of the dose parameters changes:
0.90 (particle number), 0.92 (joint length),
and 0.96 (BET surface area). The important
consequence of these two sets of regression
analyses is that I cannot safely identify one
dose parameter as serving best for quantifying
the magnitude of lung inflammation due to
instillation of carbon nanoparticles. 
c) The observation of statistically signifi-
cant deviations from the mean suggests that
one of the fundamental assumptions on
which data evaluation was based might not be
valid, the assumption that different types, j, of
carbon particles feature the same surface toxi-
city. To explore this aspect further, relative
surface toxicities τj,k,x were deﬁned as
τj,k,φ = 〈R〉j,k,φ/φ [10]
separately for the three dose parameters k (sur-
face area, joint length, and particle number)
and for all φ in the low-dose limit. Relative sur-
face toxicities τj,k were obtained as the mean of
the τj,k,φ-data available for different φ at the
same combination of j and k. Normalized sur-
face sensitivities, τn
j,k, deﬁned as
τn
j,k = τj,k/〈τj,k〉, [11]
are depicted in Figure 9 as open symbols. The
mean of these data for each particle type (solid
circles) constitutes the normalized surface toxi-
city τn
j. Two types of particles, SpD and PrtxG,
are well above the mean of unity, and two
other types, SootH and DEP, are well below.
The consequence of the observed pronounced
differences in surface toxicity is that particles
made of the same material but by different
techniques are not generally suited for identify-
ing the proper dose metric in studies designed
to determine the effect of particle size. Hence,
unless one can ﬁnd particles of the same mater-
ial and with sufﬁciently similar surface toxicity,
but with distinctly different physical parame-
ters such as size and surface area, it will be difﬁ-
cult to determine which of the physical
parameters is best suited as a dose metric.
The origin of the differences in surface
toxicity is not clear at this point. We note that
diesel exhaust particles are at the low end of sur-
face toxicity. This ﬁnding should be important
in the ongoing discussion on adverse health
effects due to traffic-related emissions. The
low toxicity of DEPs may provide an explana-
tion for the reported lack of concordance
between lung cancer risk levels and diesel
exhaust exposure (Valberg and Watson 2000). 
SootH and DEP particles were similar in
terms of low surface toxicity; both were charac-
terized as containing about 20% organic carbon
(OC; Stoeger et al. 2006). One could argue
that the presence of OC, presumably “on” the
particles, reduces the surface toxicity compared
with the “naked” particles. However, the SpD
particles contained almost the same OC frac-
tion (17%) as SootH and DEP, but the surface
toxicity of the former is high according to
Figure 9. This apparent controversy could be
resolved by arguing that without OC these
particles might have exhibited an even higher
toxicity than observed, possibly because of the
presence of small chunks and ﬂakes discussed
above. Another argument in favor of differ-
ences in surface toxicity is that in contrast to all
the other types of carbon particles discussed
here, the SpD particles were not a product of
incomplete combustion. Hence, they could
feature a morphology distinctly different from
that of the other particles. This is one of the
issues that needs to be clarified by HRTEM
investigations or by other advanced methods of
particle characterization.
Returning to the problem of nonlinear
response, it is tempting to apply the low-dose
normalization factors to the high-dose data as
well. The results of this exercise are presented
in Figure 10. Whereas at low doses only the
mean values of Figure 8 are reproduced, the
high-dose data are shown separately for all
three response parameters. Presenting the data
in this manner allows the large differences in
response at high doses to become evident. The
results support the notion, which is already
suggested by the data evaluation presented in
Figure 1B, that the use of high-dose data for
identifying the proper dose metric will give rise
to misleading conclusions. 
The data in Figure 10 should be inter-
preted carefully. Apart from suggesting a
Wittmaack
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reduced response rate at excessively high doses,
the data could also be read as providing evi-
dence that, beyond some limit, conversion
from mass to a certain dose parameter is not
correct any more. For SpD, the highest doses
correspond to a number concentration of 1.2 ×
1015 cm–3, or a joint length of 104 km/cm3, in
the instilled solution. At these large concentra-
tions one should expect to encounter very
heavy coagulation or compaction of particles,
notably in the case of those small particles that
are contained in the SpD and SootL matter.
Compaction would mean that the “true” dose
in terms of particle number, surface area, or
joint length was much lower than calculated
for individual particles. Hence, the response
data should be shifted to significantly lower
doses, as indicated by the arrows in Figure 10.
This uncertainty in dose assignment consti-
tutes yet another argument against high-dose
experiments or, alternatively, an argument for
improved methods to ensure adequate particle
dispersion during instillation (Rao et al. 2003).
The question should also be addressed as
to why three different particle parameters
were suited as dose metrics but not the surface
area calculated under the assumption of com-
pact particles. The formal answer to this ques-
tion can be found in the data presented in
Figure 11, which shows the range of relative
doses covered by the four different particle
parameters. For ease of comparison, the data
are normalized to the lowest dose, namely, to
5 μg PrtxG. The large differences in dose
range are evident. Considering the dose para-
meters derived from the size D of the parti-
cles, the differences are solely due to the fact
that mass-to-dose conversion is basically pro-
portional to D–s, with the power s increasing
from 1 through 2 to 3 for the surface area, the
joint length, and the particle number, respec-
tively. Accordingly, the corresponding maxi-
mum relative dose increases from 47 through
220 to 1,020, each time by a factor 4.7,
which equals the ratio of the largest to the
smallest particle size. The most appropriate
dose metric is the particle parameter that pro-
vides optimum “stretching” of the dose range
in terms of mass. According to the data pre-
sented in Figure 3C, dose stretching is not
sufﬁcient using the size-based surface area as a
dose metric. To achieve optimum scaling, one
has to stretch the dose scale by another
factor 22 (= 4.72); that is, one has to use the
particle number as a dose metric, as illustrated
in Figure 3D. For the PMN data discussed in
Figure 3A, the BET-based surface area pro-
vides reasonable but not optimum stretching.
This is also true for the joint length, in which
case Figure 11 indicates that the quality of
scaling is almost the same as for the BET sur-
face area (results not shown in Figure 3). 
Even though Figure 11 provides the basic
rationale for selecting the proper dose metric,
there are several reasons why a ﬁnal decision in
favor of a “best choice” is not yet possible. First,
the statistical uncertainty of the response data is
too large. Second, the observation of particle-
type dependent surface toxicity introduces an
uncertainty that cannot be resolved at present.
Third, the particle parameters and their statisti-
cal variation within a sample are not known
well enough to safely convert the particle mass
to a conceivably appropriate dose metric. 
Conclusion, Further Comments,
and Prospects
This present study has addressed several issues
and problems in the ﬁeld of ultraﬁne particles
and lung inflammation. The need for linear
dose–response studies has been demonstrated.
Such studies are possible, not only by investi-
gating a single but also multiple response para-
meters. Another problem is the large differences
in the surface toxicity that one may encounter
with particles made from the same material but
by different techniques. Such differences aggra-
vate or even exclude the identiﬁcation of the
proper dose metric, if such a parameter exists at
all. In fact, there is no reason to assume that the
contribution of the physical properties of a par-
ticle to the observed inﬂammatory response can
be fully described in simple terms such as the
size or the surface area. 
One of the most important issues concern-
ing experiments with laboratory-generated car-
bon particles relates to the question of whether
the aggregates formed during the production
process will remain intact or will dissociate after
deposition in the lung (Wittmaack 2006). In
this context it is important to note that the par-
ticle sizes determined by TEM (Stoeger et al.
2006) were derived by the analysis of rare indi-
vidual species identiﬁed on the TEM support
grid (Takenaka S, personal communication,
2006), the reason being that size evaluation
within chain aggregates is difﬁcult because of
the frequent overlay of particles. The observa-
tion that the particle number constitutes a good
if not the best dose metric for the response to
carbon particles may be considered a strong
indication that the aggregates did in fact disso-
ciate in the lung before causing inﬂammation.
Diesel soot aggregates constitute an exception.
Many (probably even most) of the individual
particles that one can identify in TEM (Bérubé
et al. 1999) and SEM (Wittmaack 2004)
images were tightly bound together during
growth; that is, the crystallites observed at the
neck between two adjacent primary particles
extend through the neck, as shown by
HRTEM (Ishiguro 1997). This state of tight
aggregation may be the most important reason
for the low surface toxicity of diesel soot. 
It must be kept in mind that in vivo studies
involving animal exposure to particulate matter
can be justiﬁed only if there is a good chance
for improving current knowledge on the
response of humans to inhaled ambient aerosol
particles. Even though the toxic potential of
ambient PM is too low to make adverse health
effects plausible (Green et al. 2002; Valberg
2004), this aspect should not remain the most
powerful argument in support of the specula-
tion that ultraﬁne particles cause the problem.
Arguments for the ultraﬁne particle hypothesis
can be misleading. Oberdörster et al. (2005)
and Nel et al. (2006) pointed out, for example,
that the surface area-to-mass ratio A/M of parti-
cles increases with decreasing particle size, as
discussed with reference to Equation 3. In toxi-
cologic studies, however, it is believed that A
not A/M is important—provided the suface
area is the proper dose metric. Previous reason-
ing (Nel et al. 2006; Oberdörster et al. 2005)
was based on the inherent assumption that the
mass concentrations of nanoparticles is reason-
ably constant over a wide range of particle sizes.
Typical size distributions of ambient PM tell a
completely different story. At urban sites it is
the (mean) number rather than the mass
concentration that is roughly constant between
20 and 200 nm (Wittmaack 2002), so that A
decreases strongly with decreasing D, as πD2N.
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as the quantity of concern, the hazard due to
ambient nanoparticles is exaggerated by a factor
proportional to 1/D3. In view of these facts I
must conclude that associations between
adverse health effects and ambient PM are
implausible with respect to both the chemical
composition (mass) and the surface area of the
particles. Unraveling this mystery is a challenge
to scientists active in environmental medicine,
toxicology, biophysics, and epidemiology. 
To illustrate the need for refinement of
current research, one example may suffice.
The size distributions of ambient PM typically
feature a fall-off in number concentration at
particle sizes below about 20 nm, to the end
that the concentrations between 5 and 10 nm
may be an order of magnitude lower than
between 20 and 200 nm (Wittmaack 2002).
Therefore, experiments involving particles
with sizes of ≤ 10 nm are of rather question-
able relevance with respect to environmental
health issues. Future in vivo studies should
focus on carbon particles in the size range
between 20 and 100 nm, including diesel soot.
In such investigations the challenge will be that
these particles produce only a comparatively
low inflammatory response, as discussed in
detail above. 
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